Scholar Rock

Developer of Antibody-based drugs for the treatment of primary myopathies

placeCambridge, Massachusetts, United States calendar_todayFounded 2012 groups150 employees language scholarrock.com

Registered entities

Innovation

41 patent families (19 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 14,505 times.

YearFilings
20153
20165
201710
201813
201913
202014
202117
202215
202319
202422
202522
202612

Social engagement

Social engagement: 21.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Invus, Fidelity Investments.

Investor typeCountShare
Venture capital217%
Private equity433%
Angel & family office18%
Accelerator & incubator18%
Other / undisclosed433%

Hiring activity

Hires periodically

8 roles tracked across 3 of the last 12 months

6 Apr 2026 · Financial Planning & Analysis Intern · Cambridge

9 Jan 2026 · Director, National Accounts · Concord

20 Nov 2025 · Director, CMC Project Management · Cambridge

6 Nov 2025 · Head of Regulatory Affairs, Europe · Aurora

Based on job postings tracked across public sources.

Recent activity

25 Jun 2026
Product launch
MYO360
24 Jun 2026
Event
Cure SMA 2026 Annual SMA Research & Clinical Care Meeting
23 Jun 2026
Event
Cure SMA Annual Conference
Coming soon